Status in Israel
Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Coated Tablets 14 X 250 mg |
|
9561 | 11028 |
|
Coated Tablets 14 X 500 mg |
|
76163 | 11016 |
Related information
Dosage
See prescribing information for full details.
Indications
Upper and lower respiratory tract infections, skin and soft tissue infections, mycobacterium avium complex (MAC) infections in AIDS, eradiation of helicobacter pylori infection in combination with PPI (protein pump inhibitor).
Contra-Indications
Hypersensitivity to clarithromycin, erythromycin or any macrolide antibiotic, patients receiving terfenadine or astemizole.
Special Precautions
N/A
Side Effects
N/A
Drug interactions
Theophylline, warfarin, digoxin, carbamazepine, terfenadine, astemizole, zidovudine, ergot derivatives.
Manufacturer
Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
Licence holder
